Foresite Capital Opportunity Management V’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Foresite Capital Opportunity Management V’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$3.48M	Hold	291,667	–	–	10.46%	5
2022 Q2	$3.68M	Hold	291,667	–	–	9.27%	5
2022 Q1	$3.28M	Hold	291,667	–	–	4.6%	8
2021 Q4	$5.17M	Buy	+291,667	New	+$6.15M	3.46%	7

Other funds holding KNTE

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return